Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huamokang granules in traumatic knee synovitis (phase II)
CTR20170525Phase 2Active
- Sponsor
- Yabao Pharmaceutical Group Co., Ltd.
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Huamoyan Keli in Traumatic synovitis of the knee, sponsored by Yabao Pharmaceutical Group Co., Ltd.. Started Aug 2017; status: active.
02
Drugs
Huamoyan Keli
03
Conditions
Traumatic synovitis of the knee
Beyond the preview
Go deeper on CTR20170525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170525.